Appropriateness of TAVR in the Chronic Liver Patient Undergoing Liver Transplant Evaluation

Authors

Rebecca Marcantuono, MSN, CRNP, Thomas Jefferson UniversityFollow
Nicholas Ruggiero, MD, Thomas Jefferson UniversityFollow
Alec Vishnevsky, MD, Thomas Jefferson UniversityFollow
John Entwistle, MD, Thomas Jefferson UniversityFollow
Praveen Mehrotra, MD, Thomas Jefferson UniversityFollow
Kiran Mahmood, MD, Thomas Jefferson UniversityFollow
Wisam Alfay, MD, Thomas Jefferson UniversityFollow

Files

Description

As the indications for Transcatheter Aortic Valve Replacement (TAVR) continue to expand, understanding appropriate patient selection is becoming an area of growing interest. The presence of Liver cirrhosis has been previously proven to increase perioperative morbidity and mortality in patients undergoing general surgical procedures. However, there is limited research articulating clinical outcomes in TAVR patients with known liver disease who are actively undergoing orthotopic liver transplant evaluation (OLT).

Publication Date

3-16-2019

Keywords

Transcatheter Aortic Valve Replacement, liver transplant

Disciplines

Cardiology | Medicine and Health Sciences

Recommended Citation

Marcantuono, MSN, CRNP, Rebecca; Ruggiero, MD, Nicholas; Vishnevsky, MD, Alec; Entwistle, MD, John; Mehrotra, MD, Praveen; Mahmood, MD, Kiran; and Alfay, MD, Wisam, "Appropriateness of TAVR in the Chronic Liver Patient Undergoing Liver Transplant Evaluation" (2019). Division of Cardiology Posters. 2.
https://jdc.jefferson.edu/cardiologyposters/2